1. |
Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med, 2014, 371(11): 1039-1049.
|
2. |
Kamisawa T, Wood LD, Itoi T, et al. Pancreatic cancer. Lancet, 2016, 388(10039): 73-85.
|
3. |
Mishra MV, Keith SW, Shen X, et al. Primary pancreatic lymphoma: a population-based analysis using the SEER program. Am J Clin Oncol, 2013, 36(1): 38-43.
|
4. |
Zucca E, Roggero E, Bertoni F, et al. Primary extranodal non-Hodgkin’s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol, 1997, 8(8): 727-737.
|
5. |
Behrns KE, Sarr MG, Strickler JG. Pancreatic lymphoma: is it a surgical disease? Pancreas, 1994, 9(5): 662-667.
|
6. |
Hamilton S, Aaltonen A. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press, 2000.
|
7. |
Nishimura R, Takakuwa T, Hoshida Y, et al. Primary pancreatic lymphoma: clinicopathological analysis of 19 cases from Japan and review of the literature. Oncology, 2001, 60(4): 322-329.
|
8. |
Battula N, Srinivasan P, Prachalias A, et al. Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas, 2006, 33(2): 192-194.
|
9. |
Sandrasegaran K, Tomasian A, Elsayes KM, et al. Hematologic malignancies of the pancreas. Abdom Imaging, 2015, 40(2): 411-423.
|
10. |
Anand D, Lall C, Bhosale P, et al. Current update on primary pancreatic lymphoma. Abdom Radiol (NY), 2016, 41(2): 347-355.
|
11. |
Sadot E, Yahalom J, Do RK, et al. Clinical features and outcome of primary pancreatic lymphoma. Ann Surg Oncol, 2015, 22(4): 1176-1184.
|
12. |
Low G, Panu A, Millo N, et al. Multimodality imaging of neoplastic and nonneoplastic solid lesions of the pancreas. Radiographics, 2011, 31(4): 993-1015.
|
13. |
Carbonetti F, Iannicelli E, Federici M, et al. Primary pancreatic Burkitt lymphoma presenting as acute pancreatitis. J Gastrointest Cancer, 2014, 45 Suppl 1: 265-269.
|
14. |
Federico E, Falconi M, Zuodar G, et al. B-cell lymphoma presenting as acute pancreatitis. Pancreatology, 2011, 11(6): 553-556.
|
15. |
Dong A, Cui Y, Gao L, et al. Patterns of FDG uptake in pancreatic non-Hodgkin’s lymphoma lesions. Abdom Imaging, 2014, 39(1): 175-186.
|
16. |
Puli SR, Bechtold ML, Buxbaum JL, et al. How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass? A meta-analysis and systematic review. Pancreas, 2013, 42(1): 20-26.
|
17. |
Hall MN, Jagannathan JP, Ramaiya NH, et al. Imaging of extraosseous myeloma: CT, PET/CT, and MRI features. AJR Am J Roentgenol, 2010, 195(5): 1057-1065.
|
18. |
Oshima K, Kanda Y, Nannya Y, et al. Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma. Am J Hematol, 2001, 67(1): 1-5.
|
19. |
Varettoni M, Corso A, Pica G, et al. Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1 003 consecutive patients. Ann Oncol, 2010, 21(2): 325-330.
|
20. |
Wu P, Davies FE, Boyd K, et al. The impact of extramedullary disease at presentation on the outcome of myeloma. Leuk Lymphoma, 2009, 50(2): 230-235.
|
21. |
Gupta P, Rice GD, Abraham K, et al. Extramedullary plasmacytoma of the pancreas and jejunum. Clin Imaging, 2009, 33(3): 240-243.
|
22. |
Patlas M, Khalili K, Dill-Macky MJ, et al. Spectrum of imaging findings in abdominal extraosseous myeloma. AJR Am J Roentgenol, 2004, 183(4): 929-932.
|
23. |
Kazama T, Ng CS, Giralt SA. Multiphasic CT and MRI appearances of extramedullary multiple myeloma involving the stomach, pancreas, and bladder. Clin Imaging, 2005, 29(4): 263-265.
|
24. |
Birjawi GA, Jalbout R, Musallam KM, et al. Abdominal manifestations of multiple myeloma: a retrospective radiologic overview. Clin Lymphoma Myeloma, 2008, 8(6): 348-351.
|
25. |
Kelekis NL, Semelka RC, Warshauer DM, et al. Nodular liver involvement in light chain multiple myeloma: appearance on US and MRI. Clin Imaging, 1997, 21(3): 207-209.
|
26. |
Moulopoulos LA, Granfield CA, Dimopoulos MA, et al. Extraosseous multiple myeloma: imaging features. AJR Am J Roentgenol, 1993, 161(5): 1083-1087.
|
27. |
Philips S, Menias C, Vikram R, et al. Abdominal manifestations of extraosseous myeloma: cross-sectional imaging spectrum. J Comput Assist Tomogr, 2012, 36(2): 207-212.
|
28. |
Girnius S, Munshi NC. Individualized therapy in multiple myeloma: are we there? Semin Oncol, 2013, 40(5): 567-576.
|
29. |
Moreau P, Touzeau C. Initial treatment of transplant candidates with multiple myeloma. Semin Oncol, 2013, 40(5): 585-591.
|
30. |
Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001: 104-105.
|
31. |
Pileri SA, Ascani S, Cox MC, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia, 2007, 21(2): 340-350.
|
32. |
Neiman RS, Barcos M, Berard C, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer, 1981, 48(6): 1426-1437.
|
33. |
Byrd JC, Weiss RB, Arthur DC, et al. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol, 1997, 15(2): 466-475.
|
34. |
Paydas S, Zorludemir S, Ergin M. Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma, 2006, 47(12): 2527-2541.
|
35. |
Messager M, Amielh D, Chevallier C, et al. Isolated granulocytic sarcoma of the pancreas: a tricky diagnostic for primary pancreatic extramedullary acute myeloid leukemia. World J Surg Oncol, 2012, 10: 13.
|
36. |
Rong Y, Wang D, Lou W, et al. Granulocytic sarcoma of the pancreas: a case report and review of the literatures. BMC Gastroenterol, 2010, 10: 80.
|
37. |
Choi EK, Byun JH, Lee SJ, et al. Imaging findings of leukemic involvement of the pancreaticobiliary system in adults. AJR Am J Roentgenol, 2007, 188(6): 1589-1595.
|
38. |
Shinagare AB, Krajewski KM, Hornick JL, et al. MRI for evaluation of myeloid sarcoma in adults: a single-institution 10-year experience. AJR Am J Roentgenol, 2012, 199(6): 1193-1198.
|
39. |
Lee EY, Anthony MP, Leung AY, et al. Utility of FDG PET/CT in the assessment of myeloid sarcoma. AJR Am J Roentgenol, 2012, 198(5): 1175-1179.
|
40. |
Yilmaz AF, Saydam G, Sahin F, et al. Granulocytic sarcoma: a systematic review. Am J Blood Res, 2013, 3(4): 265-270.
|
41. |
Chevallier P, Mohty M, Lioure B, et al. Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC. J Clin Oncol, 2008, 26(30): 4940-4943.
|
42. |
Avni B, Rund D, Levin M, et al. Clinical implications of acute myeloid leukemia presenting as myeloid sarcoma. Hematol Oncol, 2012, 30(1): 34-40.
|
43. |
Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA, 2011, 306(17): 1891-1901.
|
44. |
Bakker NA, van Imhoff GW, Verschuuren EA, et al. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transpl Int, 2007, 20(3): 207-218.
|
45. |
Végso G, Hajdu M, Sebestyén A. Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options. Pathol Oncol Res, 2011, 17(3): 443-454.
|
46. |
Parker A, Bowles K, Bradley JA, et al. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients-BCSH and BTS Guidelines. Br J Haematol, 2010, 149(5): 675-692.
|
47. |
Cohen JI. Epstein-Barr virus infection. N Engl J Med, 2000, 343(7): 481-492.
|
48. |
Babcock GJ, Decker LL, Freeman RB, et al. Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med, 1999, 190(4): 567-576.
|
49. |
Quinlan SC, Pfeiffer RM, Morton LM, et al. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol, 2011, 86(2): 206-209.
|
50. |
Swerdlow S, Campo E, Harris N. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008.
|
51. |
Pickhardt PJ, Siegel MJ. Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients. Radiology, 1999, 213(1): 73-78.
|
52. |
Blaes AH, Cioc AM, Froelich JW, et al. Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders. Clin Transplant, 2009, 23(6): 794-799.
|
53. |
Swinnen LJ. Diagnosis and treatment of transplant-related lymphoma. Ann Oncol, 2000, 11 Suppl 1: 45-48.
|
54. |
Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer, 1956, 9(4): 822-830.
|
55. |
Brandt SJ, Bodine DM, Dunbar CE, et al. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman’s disease in mice. J Clin Invest, 1990, 86(2): 592-599.
|
56. |
Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol, 2009, 16(4): 236-246.
|
57. |
Bonekamp D, Horton KM, Hruban RH, et al. Castleman disease: the great mimic. Radiographics, 2011, 31(6): 1793-1807.
|
58. |
Tey HL, Tang MB. A case of paraneoplastic pemphigus associated with Castleman’s disease presenting as erosive lichen planus. Clin Exp Dermatol, 2009, 34(8): e754-e756.
|
59. |
Ko SF, Hsieh MJ, Ng SH, et al. Imaging spectrum of Castleman’s disease. AJR Am J Roentgenol, 2004, 182(3): 769-775.
|
60. |
Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer, 1972, 29(3): 670-683.
|
61. |
Nicoli P, Familiari U, Bosa M, et al. HHV8-positive, HIV-negative multicentric Castleman’s disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. Int J Hematol, 2009, 90(3): 392-396.
|
62. |
McAdams HP, Rosado-de-Christenson M, Fishback NF, et al. Castleman disease of the thorax: radiologic features with clinical and histopathologic correlation. Radiology, 1998, 209(1): 221-228.
|
63. |
Soler R, Rodríguez E, Bello MJ, et al. Pancreatic Castleman’s disease: MR findings. Eur Radiol, 2003, 13 Suppl 4: L48-L50.
|